Arsenic toxicity, mutagenesis, and carcinogenesis - A health risk assessment and management approach

Molecular and Cellular Biochemistry

Volumn 255, Issue 1-2, 2004, Pages 47-55

  Tchounwou, Paul B ^a   Centeno, Jose A ^b   Patlolla, Anita K ^a  

^a JACKSON STATE UNIVERSITY   (United States)

^b ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

Author keywords

Arsenic; Contamination; Health effects; Risk assessment and management

Indexed keywords

ARSENIC; ARSENIC TRIOXIDE; DIMERCAPROL; DRINKING WATER; GROUND WATER; UNITHIOL;

ACUTE TOXICITY; ARSENIC POISONING; BLADDER CARCINOGENESIS; CANCER MORTALITY; CHEMICAL CARCINOGENESIS; CHEMICAL MUTAGENESIS; CHRONIC TOXICITY; COLON CARCINOGENESIS; DANGEROUS GOODS TRANSPORT; ENVIRONMENTAL MANAGEMENT; HEALTH HAZARD; HUMAN; KIDNEY CANCER; LIVER CARCINOGENESIS; PHYSICAL CHEMISTRY; PRACTICE GUIDELINE; PUBLIC HEALTH; REGULATORY MECHANISM; REVIEW; RISK ASSESSMENT; RISK MANAGEMENT; SIDE EFFECT; SKIN CARCINOGENESIS; STANDARDIZATION; TOXICOKINETICS; WATER CONTAMINATION; WATER MANAGEMENT;

ARSENIC; ARSENIC POISONING; CARCINOGENS, ENVIRONMENTAL; CELL TRANSFORMATION, NEOPLASTIC; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL HEALTH; ENVIRONMENTAL MONITORING; HUMANS; MUTAGENESIS; PRIMARY PREVENTION; RISK ASSESSMENT; SKIN NEOPLASMS; WATER POLLUTANTS, CHEMICAL;

EID: 0842308254     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:MCBI.0000007260.32981.b9     Document Type: Review

References (74)

1. Tchounwou PB, Wilson BA, Ishaque A: Important considerations in the development of public health advisories for arsenic and arsenic-containing compounds in drinking water. Rev Environ Health 14: 1-19, 1999
2. Goering PL, Aposhian HV, Mass MJ, Cebrian M, Beck BD, Waalkes MP: The enigma of arsenic carcinogenesis: Role of metabolism. Toxicol Sci 49: 5-14, 1999
3. NAS: Arsenic. National Academy of Science, Washington DC, 1977
4. Rousselot P, Laboume S, Marolleau JP, Larghero T, Noguera ML, Brouet JC, Fermand JP: Arsenic trioxide and melarsoprol induce apoptosis in plasma cell lines and in plasma cells from myeloma patients. Cancer Res 59: 1041-1048, 1999
5. Klaue B, Blum JD: Trace analyses of arsenic in drinking water by inductively coupled plasma mass spectrometry: High resolution vs. hybride generation. Anal Chem 71: 1408-1414, 1999
6. ATSDR: Toxicological Profile for Arsenic (Update). Agency for Toxic Substances and Disease Registry, USDHHS, PHS, Washington DC, 1999
7. NRC: Arsenic in Drinking Water. Washington DC, National Research Council, 1999
8. Abernathy CO, Liu YP, Longfellow D, Aposhian HV, Beck B, Fowler B, Goyer R, Menzer R, Rossman T, Thompson C et al.: Arsenic: Health effects, mechanisms of actions, and research issues. Environ Health Perspect 107: 593-597, 1999
9. ASTDR: Toxicological Profile for Arsenic TP-92/09. Agency for Toxic Substances and Disease Registry. Center for Disease Control, Atlanta, GA, 1993
10. Li JH, Rossman TC: Inhibition of DNA ligase activity by arsenite: A possible mechanism of its comutagenesis. Mol Toxicol 2: 1-9, 1989
11. Belton JC, Benson NC, Hanna ML, Taylor RT: Growth inhibition and cytotoxic effects of three arsenic compounds on cultured Chinese hamster ovary cells. J Environ Sci Health 20A: 37-72, 1985
12. Goyer RA: Toxic effects of metals. In: C.D. Klaassen (ed). Cassarett and Doull's Toxicology - The Basic Science of Poisons. McGraw Hill, New York, 1996, pp 691-736
13. Lee TC, Oshimura M, Barrett JC: Comparison of arsenic-induced cell transformation, cytotoxicity, mutation and cytogenetic effects in Syrian hamster embryo cells in culture. Carcinogenesis 6: 1421-1426, 1985
14. Landolph JR: Molecular and cellular mechanisms of transformation of C3H/10T1/2C18 and diploid human fibroblasts by unique carcinogenic, nonmutagenic metal compounds. A review. Biol Trace Elem Res 21:459-467, 1989
15. Tchounwou PB, Wilson BA, Schneider J, Ishaque A: Cytogenetic assessment of arsenic trioxide toxicity in the Mutatox, Ames II, and CAT-Tox assays. Metal Ions Biol Med 6: 89-91, 2000
16. Tchounwou PB, Wilson BA, Ishaque A, Schneider J: Atrazine potentiation of arsenic trioxide-induced cytotoxicity and gene expression in human liver carcinoma cells (HepG2). Mol Cell Biochem 222: 49-59, 2001
17. Tchounwou PB, Wilson BA, Abdelgnani AA, Ishaque AB, Patlolla AK: Differential cytotoxicity and gene expression in human liver carcinoma (HepG2) cells exposed to arsenic trioxide and monosodium acid methanearsonate (MSMA). Int J Mol Sci 3: 1117-1132, 2002
18. Jacobson Kram D, Montalbano D: The reproductive effects assessment group's report on the mutagenicity of inorganic arsenic. Environ Mutagen 7: 789-804, 1985
19. Jha AN, Noditi M, Nilsson R, Natarajan AT: Genotoxic effects of sodium arsenite on human cells Mutat Res 284: 215-221, 1992
20. Hartmann A, Speit G: Comparative investigations of the genotoxic effects of metals in the single cell gel assay and the sister-chromatid test. Environ Mol Mutagen 23: 299-305, 1994
21. Wang Z, Rossman TG: In: L.W. Cheng (ed). The Toxicology of Metals, Vol. 1. CRC Press, Boca Raton, Fl, 1996, pp 221-243
22. Barrett JC, Lamb PW, Wang TC, Lee TC: Mechanisms of arsenic-induced cell transformation. Biol Trace Elem Res 21: 421-429, 1989
23. Vega L, Gonsebatt ME, Ostrosky-Wegman P: Aneugenic effect of sodium arsenite on human lymphocytes in vitro: An individual susceptibility effect detected. Mutat Res 334: 365-373, 1995
24. Nakamuro K, Sayato Y: Comparative studies of chromosomal aberration induced by trivalent and pentavalent arsenic. Mutat Res 88: 73-80, 1981
25. Natarajan AT, Boei JJ, Darrouch F, Van Diemen PC, Doulout F, Hande MP, Ramalho AT: Current cytogenetic methods for detecting exposure and effects of mutagens and carcinogens. Environ Health Perspect 104(suppl 3): 445-458, 1996
26. Gonsebatt ME, Vega L, Salazar AM, Monteror, Guzman P, Blas J, Del Razo LM, Garcai-Vargas G, Albores A, Cebrian ME, Kelsh M, Ostrosky-Wegman P: Cytogenetic effects in human exposure to arsenic. Mutat Res 386: 219-228, 1997
27. Ramirez P, Eastmond DA, Laclette JP, Ostrosky-Wegman P: Disruption of microtubule assembly and spindle formation for the induction of aneuploid cells by sodium arsenite and vanadium pentoxide. Mutat Res 386: 291-298, 1997
28. Huang SC, Lee TC: Arsenite inhibits mitotic division and perturbs spindle dynamics in HeLa S3 cells. Carcinogenesis 19: 889-896, 1998
29. Huang SC, Huang C-YF, Lee TC: Induction of mitosis-mediated apoptosis by sodium arsenite in HeLa S3 cells. Biochem Pharmacol 60: 771-780, 2000
30. Jingbo Pi, Hiroshi Y, Yoshito K, Guifan S, Takahiko Y, Hiroyuki A, Claudia HR, Nobuhiro S: Evidence for induction of oxidative stree caused by chronic exposure of Chinese residents to arsenic contained in drinking water. Environ Health Perspect 110: 331-336, 2002
31. Cavigelli M, Li WW, Lin A, Su B, Yoshioka K, Karin M: The tumor promoter arsenite stimulates AP-1 activity by inhibiting a JNK phosphatase. EMBO J 15: 6269-6279, 1996
32. Kitchin K: Recent advances in arsenic carcinogenesis: Modes of action, animal model systems, and methylated arsenic metabolites. Toxicol Appl Pharmacol 172: 249-261, 2001
33. Simeonova PP, Luster MI: Mechanisms of arsenic carcinogenicity: Genetic or epigenetic mechanisms? J Environ Pathol Toxicol Oncol 19: 281-286, 2000
34. Barchowsky A, Dudek EJ, Treadwell MD, Wetterhahn KE: Arsenic induces oxidant stress and NFxB activation in cultured aortic endothelial cells. Free Radic Biol Med 21: 783-790, 1996
35. Salazar AM, Ostrowsky-Wegman P, Menedez D, Miranda E, Garcia-Carranca A, Rojas E: Induction of p53 protein expression by sodium arsenate. Mutat Res 381: 259-265, 1997
36. Burleson FG, Simeonova PP, Germolec DR, Luster MI: Dermatotoxic chemical stimulate of c-jun and c-fos transcription and AP-1 DNA binding in human keratinocytes. Res Common Mol Pathol Pharmacol 93:131-148, 1996
37. Simeonova PP, Wang S, Toriumi W, Kommineni C, Matheson J, Unimye N, Kayama F, Harki D, Ding M, Vallyathan V et al.: Arsenic mediates cell proliferation and gene expression in the bladder epithelium: Association with AP-1 transactivation. Cancer Res 60: 3445-3453, 2000
38. Styblo M, Drobna Z, Jaspers I, Lin S and Thomas DJ: The role of biomethylation in toxicity and carcinogenicity of arsenic: A research Update. Environ Health Perspect 110: 767-771, 2002
39. Mahata J, Basu A, Ghoshal S, Sarkar JN, Roy AK, Poddar G, Nandy AK, Banerjee A, Ray K, Natarajan AT, Nilsson R, Giri AK: Chromosomal aberrations and sister chromatid exchanges in individuals exposed to arsenic through drinking water in West Bengal, India. Mutat Res 534: 133-143, 2003
40. Ahmad S, Kitchin KT, Cullen WR: Arsenic species that cause release of iron from ferritin and generation of activated oxygen. Arch Biochem Biophys 382: 195-202, 2000
41. Zhong CX, Wang L, and Mass MJ: Differentially methylated DNA sequences associated with exposure to arsenate in cultures of human cells identified by methylation-sensitive arbitrarily-primed PCR. Toxicol Lett 122: 223-234, 2001
42. Vega L, Styblo M, Patterson R, Cullen W, Wang C, Germolec D: Differential effects of trivalent and pentavalent arsenicals on cell proliferation and cytokine secretion in normal human epidermal keratinocytes. Toxicol Appl Pharmacol 172: 225-232, 2001
43. Popovicova J, Moser GJ, Goldsworthy TL, Tice RR: Carcinogenicity and co-carcinogenicity of sodium arsenite in p53+/- male mice. Toxicologist 54: 134, 2000
44. Hanahan D, Weinberg RA: The hallmarks of cancer. Cell 100: 57-70, 2000
45. Hamadeh HK, Vargas M, Lee E, Menzel DB: Arsenic disrupts cellular levels of p53 and mdm2: A potential mechanism of carcinogenesis. Biochem Biophys Res Commun 263: 446-449, 1999
46. Boonchai W, Walsh M, Cummings M, Chenevix-Trench G: Expression of p53 in arsenic-related and sporadic basal cell carcinoma. Arch Dermatol 136: 195-198, 2000
47. Lee TC, Tanaka N, Lamb PW, Gilmer TM, Barrett JC: Induction of gene amplification by arsenic. Science 241: 79-81, 1988
48. National Research Council. Science and Judgement in Risk Assessment. Assessment of Toxicology (National Academy of Sciences, eds). Washington DC, National Academy Press, 1994, pp 56-67
49. Goulding R: Arsenic, poisoning from chemicals. In: Oxford Textbook of Medicine, Vol. 1. 2nd edn. Oxford University Press, Oxford, 1988, 6, pp 13-16
50. Gorby MS: Arsenic in human medicine. In: J.O. Nriagu (ed). Arsenic in the Environment; Part II: Human Health and Ecosystem Effects. John Wiley & Sons, Inc., New York, 1994, pp 1- 16
51. Wu MM, Kuo TL, Hwang YH: Dose-response relation between arsenic concentration in well water and mortality from cancers and vascular diseases. Am J Epidemiol 130: 1123-1132, 1989
52. Tseng WP, Chu HM, How SW, Fong JM, Lin CS, Yeh S: Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan. J Natl Cancer Inst 40: 453-463, 1968
53. Chen CJ, Chen CW, Wu MM, Kuo TL: Cancer potential in liver lung, bladder and kidney due to ingested inorganic arsenic in drinking water. Br J Cancer 66: 888-892, 1992
54. Chappell W, Beck B, Brown K, North D, Thornton I, Chaney R, Cothern R, Cothern CR, North DW, Irgolic K, Thornton I, Tsongas T: Inorganic arsenic: A need and an opportunity to improve risk assessment. Environ Health Perspect 105: 1060-1067, 1997
55. Aschengran A, Zierler S, Cohen A: Quality of community drinking water and the occurrence of spontaneous abortion. Arch Environ Health 44:283-290, 1989
56. NRCC: Effects of arsenic in the environment. National Research Council of Canada. Natl Res Counc Can Publ, 1978, pp 1-349
57. U.S. EPA. Ambient Water Quality Criteria for Arsenic. EPA400/5-80021. Environmental Protection Agency. Washington DC, 1980
58. Fierz U: Catamnestic investigations of the side effects of therapy of skin diseases with inorganic arsenic. Dermatologia 131: 41-58, 1965
59. Chiou HY, Chiou ST, Hsu YH, Chou YL, Tseng CH, Wei ML, Chen CJ: Incidence of transitional cell carcinoma and arsenic in drinking water: A follow-up study of 8,102 residents in an arseniasis-endemic area in northeastern Taiwan. Am J Epidemiol 153: 411-418, 2001
60. Chen CJ, Lin LJ: Human carcinogenicity and atherogenicity induced by chronic exposure to inorganic arsenic. In: J.O. Nriagu (ed). Arsenic in the Environment; Part II: Human Health and Ecosystem Effects. John Wiley & Sons, Inc., New York, 1994, pp 109-131
61. Risk Assessment forum. Special Report on Ingested Arsenic: Skin Cancer; Nutritional Essentiality. EPA/625/3-87/013, U.S. Environmental Protection Agency, Washington, DC, 1988
62. Marcus WL, Rispin AS: Threshold carcinogenicity using arsenic as an example. In: C.R. Cothern, M.A. Mehlman (eds). Advances in Modern Environmental Toxicology: Risk Assessment and Risk Management of Industrial and Environmental Chemicals. Princeton Publishing Company, Princeton, NJ, 1988, pp 133-158
63. Smith AH, Hopenhayn-Rich C, Bates MN, Goeden HM, Hertz-Picciotto I, Duggan HM, Wood R, Kosnett MJ, Smith MT: Cancer risks from arsenic in drinking water. Environ Health Perspect 97: 259-267, 1992
64. Warner ML, Moore LE, Smith MT: Increased micronuclei in exfoliated bladder cells of persons who chronically ingest arsenic-contaminated water in Nevada. Cancer Epidemiol Biomarkers Prev 3: 583-590, 1994
65. Rudel R, Slayton TM, Beck BD: Implications of arsenic genotoxicity for dose-response of carcinogenic effects. Regul Toxicol Pharmacol 23: 87-105, 1996
66. Mass MJ, Wang L: Alterations of methylation of the tumor suppressor gene p53: Insights into potential mechanisms of arsenic carcinogenesis. In: C.O. Abernathy, R.L. Calderon, W.R. Chappell (eds). Arsenic Exposure and Health Effects. Chapman & Hall, New York, 1997, pp 338-348
67. IARC: Monographs on the Evaluation of Carcinogenic Risks of Chemicals to Humans. Supplement F. Overall Evaluation of Carcinogenicity. International Agency for Research on Cancer. World Health Organization. Lyon, France, 1987, pp 29-57
68. IRIS: Integrated Risk Information System. U.S. EPA. Washington, DC, 1992
69. National Academy of Science: Arsenic in Drinking Water. The National Academies Press, Washington DC, 1999, pp 299-301
70. U.S. EPA: National primary drinking water regulations. Fed Regist 50: 46931-47022, 1985
71. National Research Council: Arsenic in Drinking Water. 2001 Update. On line at: http://www.nap.edu/books/0309076293/html/
72. WHO: Guidelines for Drinking Water Quality. World Health Organization, Geneva, Switzerland, 1984
73. OSHA: Occupational Safety and Health Administration. Fed Reg 54: 2332-2335, 1989
74. Jekel MR: Removal of arsenic in drinking water treatment. In: J.O. Nriagu (ed). Arsenic in the Environment, Part I: Cycling and Characterization. John Wiley & Sons, Inc., New York, 1994, pp 119-132